Dr. Karen Mohlke (Professor and Associate Chair for Research, Department of Genetics) has been recognized by the Office of Graduate Education (OGE) with one of this year’s Awards for Excellence in Basic Science Mentoring.
Katarzyna Kedziora, PhD, postdoctoral researcher in the UNC Department of Genetics, received a $740,000 Chan Zuckerberg Initiative (CZI) grant to support increased collaboration and innovations in imaging technology research.
Adriana Beltran, PhD has been appointed as Assistant Professor in the Department of Genetics, effective December 1, 2020.
Department of Genetics faculty, postdocs, students and collaborators published nine papers during November 15-28, 2020.
Drs. Katie Hoadley (Assistant Professor), Piotr Mieczkowski (Associate Professor), Joel Parker (Associate Professor), Chuck Perou (Professor), Patrick Sullivan (Professor) and Jenny Ting (Professor) have been recognized as 2020 Highly Cited Researchers.
Department of Genetics faculty, postdocs, students and collaborators published nine papers during November 1-14, 2020.
Drs. Wesley Crouse, Samir Kelada and Will Valdar (UNC Department of Genetics) published the manuscript “Inferring the Allelic Series at QTL in Multiparental Populations” in the October 20, 2020 edition of the journal GENETICS. This paper will be featured as an issue highlight in the December 2020 edition of the journal. The article follows: Multiparent … Read more
An international consortium led by UNC Departments of Genetics and Computer Science published a manuscript on the development and testing of a new tool to enhance the value of the laboratory mouse in biomedical research.
A new study by scientists at UNC Lineberger Comprehensive Cancer Center and colleagues published Oct. 30, 2020, in Science, showed that mice exposed to potentially lethal levels of total body radiation were protected from radiation damage if they had specific types of bacteria in their gut.
Department of Genetics faculty, postdocs, students and collaborators published 18 papers during October 11-31, 2020. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker JS, Huebner L, Hoadley KA, … Read more
